<result><Target><Item><Target_ID> 1675</Target_ID>
<Target_Name>Tumor necrosis factor ligand superfamily member 13</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>O75888</Target_Sequence>
<Synonyms>A proliferation-inducing ligand, APRIL
TNF- and APOL-related leukocyte expressed ligand 2, TALL-2
TNF-related death ligand 1, TRDL-1
CD_antigen: CD256</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4ZCH</Target_Structure>
<Comments>A Proliferation-Inducing Ligand (APRIL) is a ligand in the tumor necrosis factor (TNF) superfamily that functions as a soluble factor. APRIL is primarily expressed by hematopoietic cells and has biological roles in B cell survival and T cell activation.</Comments>
</Item><Item><Target_ID> 1676</Target_ID>
<Target_Name>Extradomain-B fibronectin (EDB-FN)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Extradomain-B fibronectin (EDB-FN), one of the oncofetal fibronectin (onfFN) isoforms, is a high-molecular-weight glycoprotein that mediates cell adhesion and migration. The expression of EDB-FN is associated with a number of cancer-related biological processes such as tumorigenesis, angiogenesis, and epithelial-to-mesenchymal transition (EMT). The EDB fragment used in the experiment is a type-III homology repeat with a highly conserved sequence of 91 amino acids.</Comments>
</Item><Item><Target_ID> 1677</Target_ID>
<Target_Name>Esophageal squamous carcinoma cell Eca-109 </Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1678</Target_ID>
<Target_Name>Anti-aflatoxin monoclonal antibody 1C11</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1679</Target_ID>
<Target_Name>Anti-thiacloprid monoclonal antibody 3A5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1680</Target_ID>
<Target_Name>Anti-GapC (1-150) mAb 1F2</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1681</Target_ID>
<Target_Name>His-tagged porcine reproductive and respiratory syndrome virus (PRRSV) nonstructuralprotein (nsp) 7</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1682</Target_ID>
<Target_Name>Cation-independent mannose-6-phosphate receptor</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P11717</Target_Sequence>
<Synonyms>Insulin-like growth factor II receptor, M6P/IGF2 receptor</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1E6F, 1GP0, 1GP3, 1GQB, 1JPL, 1JWG, 1LF8, 2CNJ, 2L29, 2L2A, 2M68, 2M6T, 2V5N, 2V5O, 2V5P</Target_Structure>
<Comments>IGF2R is a 300 kDa glycoprotein containing three domains, the cytoplasmic domain, transmembrane domain, and extracellular domain. The major function of IGF2R is to regulate lysosomal enzymes such as growth factor IGF2 by transporting them into lysosomes, followed by digestion by lysosomal acid hydrolases.</Comments>
</Item><Item><Target_ID> 1683</Target_ID>
<Target_Name>EC1 domain (EC187) of corticotropin-releasing factor receptor 1</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>P34998 [20-106]</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>2L27, 3EHS, 3EHT, 3EHU, 4K5Y</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1684</Target_ID>
<Target_Name>Tocilizumab</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Tocilizumab is a humanized monoclonal antibody that specifically targets both soluble interleukin-6 receptor (sIL-6R) and membrane bound interleukin-6 receptor (mIL-6R) with a high affinity, thereby preventing pro-inflammatory effects of IL-6.</Comments>
</Item><Item><Target_ID> 1685</Target_ID>
<Target_Name>Imidacloprid hapten IMI</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1686</Target_ID>
<Target_Name>Site-specifically biotinylated Complement C3 beta chain (C3b)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1687</Target_ID>
<Target_Name>Type IV secretion system protein virB10</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>Q9RPX5</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Brucella suis biovar 1 (strain 1330):204722</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1688</Target_ID>
<Target_Name>Magnesium fluoride (MgF2) particles</Target_Name>
<Target_Type>Inorganic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1689</Target_ID>
<Target_Name>Anti-coagulation factor VIII monoclonal antibody (mAb) 2-76</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1690</Target_ID>
<Target_Name>Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 1</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1691</Target_ID>
<Target_Name>Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 3</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1692</Target_ID>
<Target_Name>Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 5</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1693</Target_ID>
<Target_Name>Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 10</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1694</Target_ID>
<Target_Name>Anti-avian hepatitis E virus (HEV) capsid protein monoclonal antibody 3E8</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1695</Target_ID>
<Target_Name>Anti-avian hepatitis E virus (HEV) capsid protein monoclonal antibody 1B5</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1696</Target_ID>
<Target_Name>δ2 CDR3 peptide CACDVLGVNTDKLIFGKG</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1697</Target_ID>
<Target_Name>δ2 CDR3 peptide CACDTLGDRDYTDKLIFGKG</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1698</Target_ID>
<Target_Name>δ2 CDR3 peptide CACDTIGTGGHYTDKLIFGKG</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 1699</Target_ID>
<Target_Name>δ2 CDR3 peptide CACDTLWGIQGNTDKLIFGKG</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item></Target></result>